Renalytix Plc Share Price OTC Markets
Stocks
RENXF
GB00BYWL4Y04
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
20:50:44 10/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0659 USD | +50.38% |
|
+0.05% | -14.91% |
| 09-14 | Renalytix plc Changes Its Financial Year-End from June 30 to December 31 | CI |
| 09-08 | EARNINGS AND TRADING: Acuity eyes 'breakeven' as loss narrows | AN |
| Market Cap | 13.34M 11.7M 11.05M 10.07M 18.85M 1.28B 18.99M 132M 51.23M 653M 50.07M 48.99M 2.1B | P/E 2024 |
-0.45x | P/E 2025 | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 17.94M 15.74M 14.86M 13.55M 25.36M 1.72B 25.54M 178M 68.9M 878M 67.34M 65.89M 2.82B | EV / Sales 2024 |
11,059,330x | EV / Sales 2025 | 12,499,418x |
| Free-Float |
79.63% | Yield 2024 * |
-
| Yield 2025 | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| RENX | Delayed | |
OTC Markets
| RENXF | Delayed | |
|
Deutsche Boerse AG
| 2O9 | Delayed | |
|
Börse Stuttgart
| 2O9 | Delayed | |
|
Boerse Muenchen
| 2O9 | Real-time |
| 1 day | +50.38% | ||
| 1 week | +0.05% | ||
| Current month | +0.05% | ||
| 1 month | +0.05% | ||
| 3 months | +82.55% | ||
| 6 months | +83.57% | ||
| Current year | -14.91% |
| Current year | 0.02 |  | 0.09 |
| 1 year | 0.02 | | 0.12 |
| 3 years | 0.02 | | 0.73 |
| 5 years | 0.02 | | 12.42 |
| 10 years | 0.02 | | 17.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 14/03/2018 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 27/05/2024 |
Howard Doran
PSD | President | 65 | 29/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baines
CHM | Chairman | 62 | 04/11/2024 |
James McCullough
BRD | Director/Board Member | 58 | 14/03/2018 |
| Chairman | 74 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +50.38% | +0.05% | - | - | 49.09M | |
| -2.64% | +4.45% | +31.82% | -18.21% | 18.65B | |
| -5.20% | -1.82% | -39.80% | +24.69% | 1.85B | |
| 0.00% | +0.41% | -30.18% | +23.60% | 866M | |
| -0.11% | -0.22% | +54.26% | -2.74% | 778M | |
| +2.34% | +3.01% | -58.77% | -84.71% | 733M | |
| -0.69% | +7.10% | -29.65% | -47.29% | 686M | |
| +1.77% | +6.49% | -38.67% | -52.83% | 589M | |
| -0.69% | +8.64% | +39.17% | +89.09% | 476M | |
| +5.05% | +7.11% | -0.46% | +9.25% | 399M | |
| Average | +5.02% | +3.21% | -8.03% | -6.57% | 2.78B | |
| Weighted average by Cap. | -2.09% | +3.80% | +18.71% | -14.19% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.29 2.01 1.9 1.73 3.24 219.39 3.26 22.7 8.79 112.08 8.59 8.41 360.22 | 3 2.63 2.49 2.27 4.24 287.53 4.27 29.75 11.52 146.9 11.26 11.02 472.1 |
| Net income | -33.46M -29.36M -27.73M -25.27M -47.3M -3.21B -47.64M -332M -129M -1.64B -126M -123M -5.26B | -20.4M -17.9M -16.91M -15.41M -28.84M -1.96B -29.05M -202M -78.36M -999M -76.59M -74.94M -3.21B |
| Net Debt | 3.86M 3.38M 3.19M 2.91M 5.45M 369M 5.49M 38.23M 14.81M 189M 14.47M 14.16M 607M | 4.6M 4.04M 3.81M 3.47M 6.5M 441M 6.55M 45.62M 17.67M 225M 17.27M 16.9M 724M |
Employees
46
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
- RENXF Stock
Select your edition
All financial news and data tailored to specific country editions
